Promotion of altered hepatic foci by 2,3',4,4',5-pentachlorobiphenyl in Sprague-Dawley female rats.

The tumor promotion potential of 2,3',4,4',5-pentachlorobiphenyl (PCB-118) was studied in a two-stage initiation/promotion bioassay in female Sprague-Dawley rats. The animals were initiated by intraperitoneal administration of N-nitrosodiethylamine after partial hepatectomy. After 5 weeks of recovery, the promotion period commenced by once-weekly subcutaneous administrations of PCB-118 at six dose levels (10, 40, 160, 640, 2500, and 10,000 microg/kg body weight/week) for 20 weeks. In addition, three of these dose levels (40, 640, and 10,000 microg/kg body weight/week) were administered for 52 weeks. Evaluation of hepatic foci positive for glutathione S-transferase P demonstrated that the mono-ortho chlorine substituted congener PCB-118 significantly increased the number of foci/cm3 of liver in the two highest dose groups after 20 weeks, but did not significantly increase the percentage of the liver occupied by foci. After 52 weeks of treatment, both the percentage and the number of foci/cm3 were significantly increased in the highest dose group. A toxic equivalency factor based on foci development during 20 weeks of treatment would be less than 0.00002. Altered relative liver and thymus weights were observed after treatment with both substances as well as an induction of methyl cholanthrene- and phenobarbital-inducible isoenzymes of cytochrome P450 monooxygenase. These results show that PCB-118 has a potency to enhance foci growth in rat liver, although the potency is low compared to that of structurally related compounds.

[1]  H. Pitot,et al.  Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. , 1980, Cancer research.

[2]  U. Ahlborg,et al.  Relative tumour promoting activity of three polychlorinated biphenyls in rat liver. , 1993, European journal of pharmacology.

[3]  Linda S. Birnbaum,et al.  Toxic equivalency factors for dioxin-like PCBs , 1994 .

[4]  K. Norén,et al.  Polychlorinated Naphthalenes and Other Organochlorine Contaminants in Swedish Human Milk, 1972–1992 , 1998, Archives of environmental contamination and toxicology.

[5]  J. Clarke,et al.  Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congener-specific analysis. , 1989, Environmental health perspectives.

[6]  T. Fujita,et al.  PCBs: structure–function relationships and mechanism of action , 1985, Environmental health perspectives.

[7]  U. Ahlborg,et al.  Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital-induced promotion of hepatocarcinogenesis in rats by the type of diet and vitamin A deficiency. , 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[8]  F. Waern,et al.  Relative liver tumour promoting activity and toxicity of some polychlorinated dibenzo-p-dioxin- and dibenzofuran-congeners in female Sprague-Dawley rats. , 1991, Pharmacology & toxicology.

[9]  A. Hanberg,et al.  Risk Assessment of Polychlorinated Biphenyls (PCBs) , 1992 .

[10]  H. Issaq,et al.  Accumulation and persistence of individual polychlorinated biphenyl congeners in liver, blood, and adipose tissue of rats following dietary exposure to Aroclor® 1254 , 1994, Archives of environmental contamination and toxicology.

[11]  S. Safe,et al.  Influence of cell proliferation on initiating activity of pure polychlorinated biphenyls and complex mixtures in resistant hepatocyte in vivo assays for carcinogenicity. , 1985, Journal of the National Cancer Institute.

[12]  R B Conolly,et al.  Chemically induced cell proliferation in carcinogenesis. , 1992, IARC scientific publications.

[13]  S. Safe,et al.  Binding of polychlorinated biphenyls classified as either phenobarbitone-, 3-methylcholanthrene- or mixed-type inducers to cytosolic Ah receptor. , 1982, Chemico-biological interactions.

[14]  U. Ahlborg,et al.  Tumour promoting effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) - effects of exposure duration, administration schedule and type of diet , 1989 .

[15]  J. Huff,et al.  Carcinogenicity of TCDD in Laboratory Animals: Implications for Risk Assessment , 1993, Toxicology and industrial health.

[16]  N Ito,et al.  Medium-term bioassays for carcinogens. , 1992, IARC scientific publications.

[17]  S. Safe,et al.  Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). , 1990, Critical reviews in toxicology.

[18]  A. Buchmann,et al.  Effects of polychlorinated biphenyls in rat liver: correlation between primary subcellular effects and promoting activity. , 1991, Toxicology and applied pharmacology.

[19]  M. van den Berg,et al.  The toxicokinetics and metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) and their relevance for toxicity. , 1994, Critical reviews in toxicology.

[20]  U. Ahlborg,et al.  Inhibition of dye transfer in rat liver WB cell culture by polychlorinated biphenyls. , 1991, Pharmacology & toxicology.

[21]  K. Kenne,et al.  The ability to alter the gap junction protein expression outside GST-P positive foci in liver of rats was associated to the tumour promotion potency of different polychlorinated biphenyls. , 1997, Chemico-biological interactions.

[22]  L. Robertson,et al.  Carcinogenicity of polyhalogenated biphenyls: PCBs and PBBs. , 1990, Critical reviews in toxicology.

[23]  A. Columbano,et al.  Cell proliferation and promotion of rat liver carcinogenesis: different effect of hepatic regeneration and mitogen induced hyperplasia on the development of enzyme-altered foci. , 1990, Carcinogenesis.

[24]  H. Yamasaki,et al.  Performance of tests for cell transformation and gap-junction intercellular communication for detecting nongenotoxic carcinogenic activity. , 1992, IARC scientific publications.

[25]  S. Safe,et al.  Polychlorinated biphenyls: correlation between in vivo and in vitro quantitative structure-activity relationships (QSARs). , 1985, Journal of toxicology and environmental health.

[26]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.

[27]  J W Cameron,et al.  Measurement of cytochrome P-450 dependent dealkylation of alkoxyphenoxazones in hepatic S9s and hepatocyte homogenates: effects of dicumarol. , 1985, Mutation research.

[28]  A. Buchmann,et al.  Do structure‐activity relationships for the acute toxicity of pcbs and pbbs also apply for induction of hepatocellular carcinoma? , 1991 .

[29]  G. Williams,et al.  Lack of initiating or promoting activity of six benzodiazepine tranquilizers in rat liver limited bioassays monitored by histopathology and assay of liver and plasma enzymes. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[30]  R. Schulte‐Hermann,et al.  Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. , 1983, Cancer research.

[31]  Study of the separate and combined effects of the non-planar 2,5,2',5'- and the planar 3,4,3',4'-tetrachlorobiphenyl in liver and lymphocytes in vivo. , 1991, Carcinogenesis.